ALKEM.NS Cash Flow
Alkem Laboratories Ltd.
Profit & Loss Balance Sheet Cash Flow
Cash Flow · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-23 21:34
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Net Cash from Operating Activities | ₹1,682.50 Cr. | ₹1,948.08 Cr. | ₹1,912.84 Cr. | ₹1,963.03 Cr. | CashFlowsFromUsedInOperatingActivities |
| Net Cash from Investing Activities | ₹112.84 Cr. | ₹-1,008.51 Cr. | ₹-1,298.76 Cr. | ₹-1,667.21 Cr. | CashFlowsFromUsedInInvestingActivities |
| Net Cash from Financing Activities | ₹-1,760.82 Cr. | ₹-1,145.01 Cr. | ₹-810.99 Cr. | ₹-503.40 Cr. | CashFlowsFromUsedInFinancingActivities |
| Effect of Exchange Rate Changes | ₹7.10 Cr. | ₹-2.05 Cr. | ₹10.51 Cr. | ₹-14.46 Cr. | EffectOfExchangeRateChangesOnCashAndCashEquivalents |
| Net Increase/(Decrease) in Cash | ₹41.62 Cr. | ₹-207.49 Cr. | ₹-186.40 Cr. | ₹-222.04 Cr. | IncreaseDecreaseInCashAndCashEquivalents |
| Cash and Cash Equivalents (Closing) | ₹232.18 Cr. | ₹273.80 Cr. | N/A | N/A | CashAndCashEquivalentsCashFlowStatement |
Every figure above is the exact value of the named XBRL element from ALKEM.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).